One of Mission’s largest employers announced mass layoffs in the company, citing financial concerns and a “challenging ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

Synthego, a Redwood City biotech company that raised millions but saw its debt costs become insurmountable, declared ...

Bankrupt genetic testing company 23andMe has been sold to Regeneron Pharmaceuticals for $256 million. The deal includes ...

The sale was for $256 million and is expected to be complete by the third quarter of this year, according to a Regeneron news ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

The acquisition marks a turning point for the company after months of financial uncertainty and data breach concerns.

In an effort to become more nimble, some companies, like Bayer Pharmaceutical, are getting rid of middle managers.

A Bay Area biotech company that laid off dozens of people this week has blamed the job cuts on policies of the Trump ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

In a world shaped by biotechnology, why are so few college students exposed to its possibilities early on in their education?